Overuse of Short-Acting Beta-2 Agonists (SABAs) in Elite Athletes: Hypotheses to Explain It

The use of short-acting beta-2 agonists (SABAs) is more common in elite athletes than in the general population, especially in endurance sports. The World Anti-Doping Code places some restrictions on prescribing inhaled β2-agonists. These drugs are used in respiratory diseases (such as asthma) that...

Descripción completa

Detalles Bibliográficos
Autores principales: Vertadier, Nicolas, Trzepizur, Wojciech, Faure, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952427/
https://www.ncbi.nlm.nih.gov/pubmed/35324645
http://dx.doi.org/10.3390/sports10030036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8952427/
https://www.ncbi.nlm.nih.gov/pubmed/35324645
http://dx.doi.org/10.3390/sports10030036

Ejemplares similares